(Reuters) -Indian contract drugmaker Anthem Biosciences filed for a 33.95-billion-rupee ($397 million) initial public offering, draft papers showed on Tuesday, at the fag end of what has been a ...

News for Syngene International Ltd. Syngene CEO Jonathan Hunt Steps Down, Peter Bains Appointed - Business News Syngene International's MD & CEO Jonathan Hunt has stepped down, with Peter Bains ...

Archbishop Shaw closed out the regular season with a dominant showing against the Willow School. The Eagles soared to an ...

After hours: February 20 at 6:46:07 PM EST Loading Chart for DTIL ...

A total of 66 companies have submitted applications for IPOs, with highly anticipated offerings from Hero Fincorp and LG ...

After hours: February 18 at 4:02:36 PM EST Loading Chart for CSTL ...

Commissions do not affect our editors' opinions or evaluations. Anthem offers various Medicare Advantage plans (also known as Medicare Part C) that provide benefits often missing from Original ...

Anthem Blue Cross Blue Shield has a large network of doctors, but you can often find better rates and customer service with another company. Anthem insurance plans have good coverage, but you can ...